{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:24:19Z","timestamp":1793298259309,"version":"4.5.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s13346-021-00897-7","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T05:49:26Z","timestamp":1610430566000},"page":"197-212","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Topical and transdermal delivery with diseased human skin: passive and iontophoretic delivery of hydrocortisone into psoriatic and eczematous skin"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3054-7870","authenticated-orcid":false,"given":"Behnam","family":"Dasht Bozorg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9990-0062","authenticated-orcid":false,"given":"Sonalika A.","family":"Bhattaccharjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2317-3305","authenticated-orcid":false,"given":"Mahadevabharath R.","family":"Somayaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4005-5359","authenticated-orcid":false,"given":"Ajay K.","family":"Banga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,11]]},"reference":[{"key":"897_CR1","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1038\/jid.2013.446","volume":"134","author":"RJ Hay","year":"2014","unstructured":"Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP, Margolis DJ, et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol Elsevier Masson SAS. 2014;134:1527\u201334.","journal-title":"J Invest Dermatol Elsevier Masson SAS"},{"key":"897_CR2","doi-asserted-by":"crossref","unstructured":"Lim HW, Collins SAB, Resneck JS, Bolognia JL, Hodge JA, Rohrer TA, et al. The burden of skin disease in the United States. J Am Acad Dermatol. Elsevier Inc; 2017;76:958\u2013972.e2.","DOI":"10.1016\/j.jaad.2016.12.043"},{"key":"897_CR3","doi-asserted-by":"crossref","unstructured":"Mounessa J, Braunberger T, Dunnick CA, Dellavalle RP. Minimal improvements in the global burden of skin disease from 1990 to 2013. J Am Acad Dermatol. Elsevier Inc; 2017;76:148\u20139.","DOI":"10.1016\/j.jaad.2016.08.006"},{"key":"897_CR4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1529-8019.2008.00170.x","volume":"21","author":"J Hong","year":"2008","unstructured":"Hong J, Koo B, Koo J. The psychosocial and occupational impact of chronic skin disease. Dermatol Ther. 2008;21:54\u20139.","journal-title":"Dermatol Ther"},{"key":"897_CR5","doi-asserted-by":"publisher","unstructured":"Andersen LK, Davis MDP. The epidemiology of skin and skin-related diseases: a review of population-based studies performed by using the rochester epidemiology project. Mayo Clin Proc [Internet]. Elsevier Inc; 2013;88:1462\u20137. Available from: https:\/\/doi.org\/10.1016\/j.mayocp.2013.08.018","DOI":"10.1016\/j.mayocp.2013.08.018"},{"key":"897_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/ard.2004.033217","volume":"64","author":"RGB Langley","year":"2005","unstructured":"Langley RGB, Krueger GG, Griffiths CEM. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis. 2005;64:18\u201323.","journal-title":"Ann Rheum Dis"},{"key":"897_CR7","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1016\/S0190-9622(03)01136-8","volume":"49","author":"J Choi","year":"2003","unstructured":"Choi J, Koo JY. Quality of life issues in psoriasis. J Am Acad Dermatol. 2003;49:S57-61.","journal-title":"J Am Acad Dermatol"},{"key":"897_CR8","first-page":"1","volume":"11","author":"M Daghem","year":"2018","unstructured":"Daghem M, Newby D. Psoriasis and inflammation more than skin deep. Allergol Int. 2018;11:1\u20133.","journal-title":"Allergol Int"},{"key":"897_CR9","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"WH Boehncke","year":"2015","unstructured":"Boehncke WH, Sch\u00f6n MP. Psoriasis Lancet. 2015;386:983\u201394177.","journal-title":"Psoriasis Lancet"},{"key":"897_CR10","unstructured":"Law RM, Gulliver WP. Psoriasis. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, editors. Pharmacother A Pathophysiol Approach, 10e. New York, NY: McGraw-Hill Education; 2017."},{"key":"897_CR11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ejphar.2005.12.052","volume":"533","author":"PJ Barnes","year":"2006","unstructured":"Barnes PJ. Corticosteroids: The drugs to beat. Eur J Pharmacol. 2006;533:2\u201314.","journal-title":"Eur J Pharmacol"},{"key":"897_CR12","unstructured":"Law RM, Kwa PG. Atopic Dermatitis. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, editors. Pharmacother A Pathophysiol Approach, 10e [Internet]. New York, NY: McGraw-Hill Education; 2017. Available from: http:\/\/accesspharmacy.mhmedical.com\/content.aspx?aid=1145203809"},{"key":"897_CR13","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1056\/NEJMra074081","volume":"358","author":"T Bieber","year":"2008","unstructured":"Bieber T. Atopic Dermatitis. N Engl J Med. 2008;358:1483\u201394.","journal-title":"N Engl J Med"},{"key":"897_CR14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jaci.2006.04.043","volume":"118","author":"H Williams","year":"2006","unstructured":"Williams H, Flohr C. How epidemiology has challenged 3 prevailing concepts about atopic dermatitis. J Allergy Clin Immunol. 2006;118:209\u201313.","journal-title":"J Allergy Clin Immunol"},{"key":"897_CR15","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1046\/j.1365-2133.2003.04934.x","volume":"148","author":"M Furue","year":"2003","unstructured":"Furue M, Terao H, Rikihisa W, Urabe K, Kinukawa N, Nose Y, et al. Clinical dose and adverse effects of topical steroids in daily management of atopic dermatitis. Br J Dermatol. 2003;148:128\u201333.","journal-title":"Br J Dermatol"},{"key":"897_CR16","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1038\/jid.1983.12","volume":"80","author":"PM Elias","year":"1983","unstructured":"Elias PM. Epidermal lipids, barrier function, and desquamation. J Invest Dermatol. 1983;80:S44\u20139.","journal-title":"J Invest Dermatol"},{"key":"897_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2165\/00128071-200304020-00004","volume":"4","author":"L Coderch","year":"2003","unstructured":"Coderch L, L\u00f3pez O, de la Maza A, Parra JL. Ceramides and skin function. Am J Clin Dermatol. 2003;4:107\u201329.","journal-title":"Am J Clin Dermatol"},{"key":"897_CR18","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1172\/JCI115439","volume":"88","author":"WM Holleran","year":"1991","unstructured":"Holleran WM, Man MQ, Gao WN, Menon GK, Elias PM, Feingold KR. Sphingolipids are required for mammalian epidermal barrier function. Inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation. J Clin Invest. 1991;88:1338\u201345.","journal-title":"J Clin Invest."},{"key":"897_CR19","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/s00403-005-0551-2","volume":"296","author":"H Farwanah","year":"2005","unstructured":"Farwanah H, Raith K, Neubert RHH, Wohlrab J. Ceramide profiles of the uninvolved skin in atopic dermatitis and psoriasis are comparable to those of healthy skin. Arch Dermatol Res. 2005;296:514\u201321.","journal-title":"Arch Dermatol Res"},{"key":"897_CR20","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1016\/j.bbamem.2006.06.021","volume":"1758","author":"JA Bouwstra","year":"2006","unstructured":"Bouwstra JA, Ponec M. The skin barrier in healthy and diseased state. Biochim Biophys Acta - Biomembr. 2006;1758:2080\u201395.","journal-title":"Biochim Biophys Acta - Biomembr"},{"key":"897_CR21","doi-asserted-by":"publisher","unstructured":"Fang YP, Yang SH, Lee CH, Aljuffali IA, Kao HC, Fang JY. What is the discrepancy between drug permeation into\/across intact and diseased skins? Atopic dermatitis as a model. Int J Pharm [Internet]. Elsevier B.V.; 2016;497:277\u201386. Available from: https:\/\/doi.org\/10.1016\/j.ijpharm.2015.12.006","DOI":"10.1016\/j.ijpharm.2015.12.006"},{"key":"897_CR22","doi-asserted-by":"crossref","unstructured":"Kezic S, Nielsen JB. Absorption of chemicals through compromised skin. Int. Arch. Occup. Environ. Health. Springer; 2009. p. 677\u201388.","DOI":"10.1007\/s00420-009-0405-x"},{"key":"897_CR23","doi-asserted-by":"crossref","unstructured":"Baboota S, Sharma S, Kumar A, Alam MS, Sahni J, Ali J. Nanocarrier-based hydrogel of betamethasone dipropionate and salicylic acid for treatment of psoriasis. Int J Pharm Investig. EManuscript Services; 2011;1:139.","DOI":"10.4103\/2230-973X.85963"},{"key":"897_CR24","doi-asserted-by":"crossref","unstructured":"Marjukka Suhonen T, A. Bouwstra J, Urtti A. Chemical enhancement of percutaneous absorption in relation to stratum corneum structural alterations. J Control Release. Elsevier; 1999;59:149\u201361.","DOI":"10.1016\/S0168-3659(98)00187-4"},{"key":"897_CR25","doi-asserted-by":"crossref","unstructured":"Carvajal-Vidal P, Mallandrich M, Garc\u00eda M, Calpena A. Effect of different skin penetration promoters in halobetasol propionate permeation and retention in human skin. Int J Mol Sci [Internet]. 2017;18:2475. Available from: http:\/\/www.mdpi.com\/1422-0067\/18\/11\/2475","DOI":"10.3390\/ijms18112475"},{"key":"897_CR26","doi-asserted-by":"crossref","unstructured":"Banga AK. Electrically assisted transdermal and topical drug delivery [Internet]. London: CRC Press; 1998. Available from: https:\/\/www.taylorfrancis.com\/books\/9780203483985","DOI":"10.4324\/9780203483985"},{"key":"897_CR27","doi-asserted-by":"crossref","unstructured":"Kalia YN, Naik A, Garrison J, Guy RH. Iontophoretic drug delivery. Adv Drug Deliv Rev [Internet]. 2004;56:619\u201358. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X03002424","DOI":"10.1016\/j.addr.2003.10.026"},{"key":"897_CR28","doi-asserted-by":"crossref","unstructured":"Pikal MJ. The role of electroosmotic flow in transdermal iontophoresis. Adv Drug Deliv Rev [Internet]. 2001;46:281\u2013305. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X00001381","DOI":"10.1016\/S0169-409X(00)00138-1"},{"key":"897_CR29","doi-asserted-by":"crossref","unstructured":"Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol [Internet]. 2008;26:1261\u20138. Available from: http:\/\/www.nature.com\/articles\/nbt.1504","DOI":"10.1038\/nbt.1504"},{"key":"897_CR30","doi-asserted-by":"crossref","unstructured":"Costello CT, Jeske AH. Iontophoresis: Applications in transdermal medication delivery. Phys Ther [Internet]. 1995;75:554\u201363. Available from: https:\/\/academic.oup.com\/ptj\/article\/2632948\/Iontophoresis:","DOI":"10.1093\/ptj\/75.6.554"},{"key":"897_CR31","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/ajd.12029","volume":"54","author":"Q Van Le","year":"2013","unstructured":"Van Le Q, Howard A. Dexamethasone iontophoresis for the treatment of nail psoriasis. Australas J Dermatol. 2013;54:115\u20139.","journal-title":"Australas J Dermatol"},{"key":"897_CR32","first-page":"163","volume":"8","author":"E Abd","year":"2016","unstructured":"Abd E, Yousuf S, Pastore M, Telaprolu K, Mohammed Y, Namjoshi S, et al. Skin models for the testing of transdermal drugs. Clin Pharmacol Adv Appl. 2016;8:163\u201376.","journal-title":"Clin Pharmacol Adv Appl"},{"key":"897_CR33","first-page":"385","volume-title":"Vivo Exam Ski A Handb Non-invasive methods","author":"W Westerhof","year":"1995","unstructured":"Westerhof W. CIE colorimetry. In: Serup J, Jemec GBE, editors. Vivo Exam Ski A Handb Non-invasive methods. Boca Raton, FL: CRC Press; 1995. p. 385\u201395."},{"key":"897_CR34","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1034\/j.1600-0846.2000.006004230.x","volume":"6","author":"P Charys","year":"2000","unstructured":"Charys P, Alewaeters K, Lambrecht R, Bare AO. Skin color measurements: comparison between three instruments: the Chromameter, the Derma Spectro-meter and the Mexameter. Ski Res Technol. 2000;6:230\u20138.","journal-title":"Ski Res Technol"},{"key":"897_CR35","doi-asserted-by":"crossref","unstructured":"Alexander H, Brown S, Danby S, Flohr C. Research techniques made simple: transepidermal water loss measurement as a research tool. J Invest Dermatol [Internet]. 2018;138:2295\u20132300.e1. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X18325764","DOI":"10.1016\/j.jid.2018.09.001"},{"key":"897_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12248-018-0272-z","volume":"21","author":"Y Jiang","year":"2019","unstructured":"Jiang Y, Murnane KS, Bhattaccharjee SA, Blough BE, Banga AK. Skin delivery and irritation potential of phenmetrazine as a candidate transdermal formulation for repurposed indications. AAPS J The AAPS Journal. 2019;21:1\u20139.","journal-title":"AAPS J The AAPS Journal"},{"key":"897_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jconrel.2003.08.002","volume":"93","author":"SN Murthy","year":"2003","unstructured":"Murthy SN, Sen A, Zhao YL, Hui SW. pH influences the postpulse permeability state of skin after electroporation. J Control Release. 2003;93:49\u201357.","journal-title":"J Control Release"},{"key":"897_CR38","doi-asserted-by":"publisher","unstructured":"Guttman-Yassky E, Nograles KE, Krueger JG. Contrasting pathogenesis of atopic dermatitis and psoriasis - Part I: clinical and pathologic concepts. J Allergy Clin Immunol [Internet]. Elsevier Ltd; 2011;127:1110\u20138. Available from:\u00a0https:\/\/doi.org\/10.1016\/j.jaci.2011.01.053","DOI":"10.1016\/j.jaci.2011.01.053"},{"key":"897_CR39","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.ejpb.2007.06.005","volume":"68","author":"FK Akomeah","year":"2008","unstructured":"Akomeah FK, Martin GP, Muddle AG, Brown MB. Effect of abrasion induced by a rotating brush on the skin permeation of solutes with varying physicochemical properties. Eur J Pharm Biopharm Elsevier. 2008;68:724\u201334.","journal-title":"Eur J Pharm Biopharm Elsevier"},{"key":"897_CR40","first-page":"884","volume":"156","author":"Y Matsunaga","year":"2007","unstructured":"Matsunaga Y, Ogura Y, Ehama R, Amano S, Nishiyama T, Tagami H. Establishment of a mouse skin model of the lichenification in human chronic eczematous dermatitis. Br J Dermatol Wiley Online Library. 2007;156:884\u201391.","journal-title":"Br J Dermatol Wiley Online Library"},{"key":"897_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/srt.12235","volume":"22","author":"AK D\u0105browska","year":"2016","unstructured":"D\u0105browska AK, Rotaru G, Derler S, Spano F, Camenzind M, Annaheim S, et al. Materials used to simulate physical properties of human skin. Ski Res Technol Wiley Online Library. 2016;22:3\u201314.","journal-title":"Ski Res Technol Wiley Online Library"},{"key":"897_CR42","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.alit.2014.06.001","volume":"64","author":"K Arima","year":"2016","unstructured":"Arima K, Ohta S, Takagi A, Shiraishi H, Masuoka M, Ontsuka K, et al. Periostin contributes to epidermal hyperplasia in psoriasis common to atopic dermatitis. Allergol Int. 2016;64:41\u20138.","journal-title":"Allergol Int"},{"key":"897_CR43","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000056387","volume":"14","author":"PM Elias","year":"2001","unstructured":"Elias PM, Feingold KR. Coordinate regulation of epidermal differentiation and barrier homeostasis. Skin Pharmacol Appl Skin Physiol. 2001;14:28\u201334.","journal-title":"Skin Pharmacol Appl Skin Physiol"},{"key":"897_CR44","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1038\/sj.jid.5700742","volume":"127","author":"K Ikeyama","year":"2007","unstructured":"Ikeyama K, Fuziwara S, Denda M. Topical application of neuronal nitric oxide synthase inhibitor accelerates cutaneous barrier recovery and prevents epidermal hyperplasia induced by barrier disruption. J Invest Dermatol. 2007;127:1713\u20139.","journal-title":"J Invest Dermatol"},{"key":"897_CR45","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.tiv.2018.04.009","volume":"51","author":"Q Zhang","year":"2018","unstructured":"Zhang Q, Murawsky M, LaCount T, Kasting GB, Li SK. Transepidermal water loss and skin conductance as barrier integrity tests. Toxicol Vitr Elsevier. 2018;51:129\u201335.","journal-title":"Toxicol Vitr Elsevier"},{"key":"897_CR46","first-page":"126","volume":"37","author":"O Braun-Falco","year":"1986","unstructured":"Braun-Falco O. Korting HC [Normal pH value of human skin]. Hautarzt. 1986;37:126\u20139.","journal-title":"Hautarzt"},{"key":"897_CR47","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1159\/000094670","volume":"19","author":"M-H Schmid-Wendtner","year":"2006","unstructured":"Schmid-Wendtner M-H, Korting HC. The pH of the skin surface and its impact on the barrier function. Skin Pharmacol Physiol. 2006;19:296\u2013302.","journal-title":"Skin Pharmacol Physiol"},{"key":"897_CR48","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2165\/00128071-200405040-00002","volume":"5","author":"F Rippke","year":"2004","unstructured":"Rippke F, Schreiner V, Doering T, Maibach HI. Stratum corneum ph in atopic dermatitis. Am J Clin Dermatol. 2004;5:217\u201323.","journal-title":"Am J Clin Dermatol"},{"key":"897_CR49","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/srt.12299","volume":"23","author":"SP Cannav\u00f2","year":"2017","unstructured":"Cannav\u00f2 SP, Guarneri F, Giuffrida R, Aragona E, Guarneri C. Evaluation of cutaneous surface parameters in psoriatic patients. Ski Res Technol. 2017;23:41\u20137.","journal-title":"Ski Res Technol"},{"key":"897_CR50","first-page":"167","volume":"154","author":"M Delfino","year":"2003","unstructured":"Delfino M, Russo N, Migliaccio G, Carraturo N. Experimental study on efficacy of thermal muds of Ischia Island combined with balneotherapy in the treatment of psoriasis vulgaris with plaques. Clin Ter. 2003;154:167\u201371.","journal-title":"Clin Ter"},{"key":"897_CR51","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jconrel.2004.11.035","volume":"103","author":"J Levin","year":"2005","unstructured":"Levin J, Maibach H. The correlation between transepidermal water loss and percutaneous absorption: an overview. J Control release Elsevier. 2005;103:291\u20139.","journal-title":"J Control release Elsevier"},{"key":"897_CR52","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1001\/archderm.1985.01660050094022","volume":"121","author":"H Tagami","year":"1985","unstructured":"Tagami H. Interrelationship between water-barrier and reservoir functions of pathologic stratum corneum. Arch Dermatol. 1985;121:642.","journal-title":"Arch Dermatol"},{"key":"897_CR53","doi-asserted-by":"crossref","unstructured":"Cork MJ, Danby S, Vasilopoulos Y, Moustafa M, MacGowan A, Varghese J, et al. Epidermal barrier dysfunction in atopic dermatitis. Textb Atopic Dermat. CRC Press; 2008. p. 47\u201370.","DOI":"10.3109\/9780203091449-8"},{"key":"897_CR54","doi-asserted-by":"crossref","unstructured":"Irvine AD, McLean WHI, Leung DYM. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med. Mass Medical Soc; 2011;365:1315\u201327.","DOI":"10.1056\/NEJMra1011040"},{"key":"897_CR55","doi-asserted-by":"crossref","unstructured":"Nikam VN, Monteiro RC, Dandakeri S, Bhat RM. Transepidermal water loss in psoriasis: a case-control study. Indian Dermatol Online J. Wolters Kluwer--Medknow Publications; 2019;10:267.","DOI":"10.4103\/idoj.IDOJ_180_18"},{"key":"897_CR56","doi-asserted-by":"publisher","first-page":"168","DOI":"10.5021\/ad.2012.24.2.168","volume":"24","author":"Y Lee","year":"2012","unstructured":"Lee Y, Je Y-J, Lee S-S, Li ZJ, Choi D-K, Kwon Y-B, et al. Changes in transepidermal water loss and skin hydration according to expression of aquaporin-3 in psoriasis. Ann Dermatol. 2012;24:168\u201374.","journal-title":"Ann Dermatol"},{"key":"897_CR57","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.tiv.2003.10.004","volume":"18","author":"DJ Davies","year":"2004","unstructured":"Davies DJ, Ward RJ, Heylings JR. Multi-species assessment of electrical resistance as a skin integrity marker for in vitro percutaneous absorption studies. Toxicol Vitr Elsevier. 2004;18:351\u20138.","journal-title":"Toxicol Vitr Elsevier"},{"key":"897_CR58","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000314995","volume":"24","author":"S Gattu","year":"2010","unstructured":"Gattu S, Maibach HI. Modest but increased penetration through damaged skin: an overview of the in vivo human model. Skin Pharmacol Physiol. 2010;24:2\u20139.","journal-title":"Skin Pharmacol Physiol"},{"key":"897_CR59","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/jat.1773","volume":"32","author":"A Chiang","year":"2012","unstructured":"Chiang A, Tudela E, Maibach HI. Percutaneous absorption in diseased skin: an overview. J Appl Toxicol. 2012;32:537\u201363.","journal-title":"J Appl Toxicol"},{"key":"897_CR60","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrd1304","volume":"3","author":"MR Prausnitz","year":"2004","unstructured":"Prausnitz MR, Mitragotri S, Langer R. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov. 2004;3:115\u201324.","journal-title":"Nat Rev Drug Discov"},{"key":"897_CR61","first-page":"119584","volume-title":"Banga AK","author":"P Bakshi","year":"2020","unstructured":"Bakshi P, Vora D, Hemmady K. Banga AK. Iontophoretic skin delivery systems: Success and failures. Int J Pharm. Elsevier; 2020. p. 119584."},{"key":"897_CR62","doi-asserted-by":"crossref","unstructured":"Coondoo A, Phiske M, Verma S, Lahiri K. Side-effects of topical steroids: A long overdue revisit. Indian Dermatol Online J. Wolters Kluwer--Medknow Publications; 2014;5:416.","DOI":"10.4103\/2229-5178.142483"},{"key":"897_CR63","unstructured":"Ltd. C. Chemicalize - Instant Cheminformatics Solutions."},{"key":"897_CR64","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/j.2042-7158.1998.tb06897.x","volume":"50","author":"SL Chang","year":"1998","unstructured":"Chang SL, Banga AK. Transdermal iontophoretic delivery of hydrocortisone from cyclodextrin solutions. J Pharm Pharmacol. 1998;50:635\u201340.","journal-title":"J Pharm Pharmacol"},{"key":"897_CR65","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1081\/PDT-100102036","volume":"5","author":"Y Wang","year":"2000","unstructured":"Wang Y, Allen LV, Li LC. Effect of sodium dodecyl sulfate on iontophoresis of hydrocortisone across hairless mouse skin. Pharm Dev Technol. 2000;5:533\u201342.","journal-title":"Pharm Dev Technol"},{"key":"897_CR66","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1002\/jps.2600821115","volume":"82","author":"Y Wang","year":"1993","unstructured":"Wang Y, Allen LV, Li LC, Tu Y-H. Iontophoresis of hydrocortisone across hairless mouse skin: investigation of skin alteration. J Pharm Sci. 1993;82:1140\u20134.","journal-title":"J Pharm Sci"},{"key":"897_CR67","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0378-5173(94)90270-4","volume":"106","author":"SC Seth","year":"1994","unstructured":"Seth SC, Alien LV, Pinnamaraju P. Stability of hydrocortisone salts during iontophoresis. Int J Pharm. 1994;106:7\u201314.","journal-title":"Int J Pharm"},{"key":"897_CR68","doi-asserted-by":"publisher","first-page":"339","DOI":"10.4155\/tde.12.1","volume":"3","author":"A Herwadkar","year":"2012","unstructured":"Herwadkar A, Banga AK. An update on the application of physical technologies to enhance intradermal and transdermal drug delivery. Ther Deliv. 2012;3:339\u201355.","journal-title":"Ther Deliv"},{"key":"897_CR69","doi-asserted-by":"crossref","unstructured":"Banga AK. Transdermal and Intradermal Delivery of Therapeutic Agents [Internet]. 1st Editio. Boca Raton: CRC Press; 2011. Available from: https:\/\/www.taylorfrancis.com\/books\/9781439805107","DOI":"10.1201\/b10906"},{"key":"897_CR70","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ijpharm.2017.06.041","volume":"528","author":"A Puri","year":"2017","unstructured":"Puri A, Murnane KS, Blough BE, Banga AK. Effects of chemical and physical enhancement techniques on transdermal delivery of 3-fluoroamphetamine hydrochloride. Int J Pharm. 2017;528:452\u201362.","journal-title":"Int J Pharm"},{"key":"897_CR71","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1001\/archderm.1966.01600290113020","volume":"94","author":"RD Carr","year":"1966","unstructured":"Carr RD, Tarnowski WM. The corticosteroid reservoir: lack of physiologic and therapeutic significance. Arch Dermatol American Medical Association. 1966;94:639\u201342.","journal-title":"Arch Dermatol American Medical Association"},{"key":"897_CR72","unstructured":"Foreman MI, Clanachan I. A preliminary estimate of the energy requirement for steroid diffusion and binding within human stratum-corneum. Br J Dermatol. Oxford: Blackwell Science Ltd.; 1984. p. 709\u201310."},{"key":"897_CR73","doi-asserted-by":"crossref","unstructured":"James MP ea, Graham RM, English J. Percutaneous iontophoresis of prednisolone\u2013a pharmacokinetic study. Clin Exp Dermatol. Wiley Online Library; 1986;11:54\u201361.","DOI":"10.1111\/j.1365-2230.1986.tb00424.x"},{"key":"897_CR74","doi-asserted-by":"crossref","unstructured":"Banga AK. Transdermal and intradermal delivery of therapeutic agents: application of physical technologies. CRC Press; 2011.","DOI":"10.1201\/b10906"},{"key":"897_CR75","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1208\/s12249-008-9107-z","volume":"9","author":"A Fini","year":"2008","unstructured":"Fini A, Bergamante V, Ceschel GC, Ronchi C, De Moraes CAF. Control of transdermal permeation of hydrocortisone acetate from hydrophilic and lipophilic formulations. AAPS PharmSciTech Springer. 2008;9:762\u20138.","journal-title":"AAPS PharmSciTech Springer"},{"key":"897_CR76","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/0169-409X(92)90027-N","volume":"9","author":"PW Ledger","year":"1992","unstructured":"Ledger PW. Skin biological issues in electrically enhanced transdermal delivery. Adv Drug Deliv Rev. 1992;9:289\u2013307.","journal-title":"Adv Drug Deliv Rev"},{"key":"897_CR77","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ejpb.2013.06.009","volume":"86","author":"T Gratieri","year":"2014","unstructured":"Gratieri T, Pujol-Bello E, Gelfuso GM, de Souza JG, Lopez RFV, Kalia YN. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle. Eur J Pharm Biopharm Elsevier. 2014;86:219\u201326.","journal-title":"Eur J Pharm Biopharm Elsevier"},{"key":"897_CR78","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1023\/A:1015854728278","volume":"9","author":"SC McNeill","year":"1992","unstructured":"McNeill SC, Potts RO, Francoeur ML. Local enhanced topical delivery (LETD) of drugs: does it truly exist? Pharm Res Springer. 1992;9:1422\u20137.","journal-title":"Pharm Res Springer"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-021-00897-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-021-00897-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-021-00897-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T03:33:47Z","timestamp":1674876827000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-021-00897-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,11]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["897"],"URL":"https:\/\/doi.org\/10.1007\/s13346-021-00897-7","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,11]]},"assertion":[{"value":"5 January 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"The tissues utilized were procured by the National Disease Research Interchange (NDRI) with support from NIH grant U42OD11158. All NDRI consent forms and protocols are reviewed and approved by the Institutional Review Board at the University of Pennsylvania. All samples obtained through one of National Disease Research Interchange\u2019s (NDRI\u2019s) tissue acquisition sites had obtained informed consent in writing for the use of that tissue for research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"The author signs for and accepts responsibility for releasing this material on behalf of any and all co-authors, and tissue source, National Disease Research Interchange (NDRI).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}